IT201700006374A1 - Sali di acidi retinoici per il trattamento della psoriasi - Google Patents

Sali di acidi retinoici per il trattamento della psoriasi

Info

Publication number
IT201700006374A1
IT201700006374A1 IT102017000006374A IT201700006374A IT201700006374A1 IT 201700006374 A1 IT201700006374 A1 IT 201700006374A1 IT 102017000006374 A IT102017000006374 A IT 102017000006374A IT 201700006374 A IT201700006374 A IT 201700006374A IT 201700006374 A1 IT201700006374 A1 IT 201700006374A1
Authority
IT
Italy
Prior art keywords
psoriasis
salts
treatment
retinoic acids
retinoic
Prior art date
Application number
IT102017000006374A
Other languages
English (en)
Inventor
Angelis Carlo De
Daniele Biagioni
Original Assignee
Angelis Carlo De
Daniele Biagioni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelis Carlo De, Daniele Biagioni filed Critical Angelis Carlo De
Priority to IT102017000006374A priority Critical patent/IT201700006374A1/it
Publication of IT201700006374A1 publication Critical patent/IT201700006374A1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
IT102017000006374A 2017-01-20 2017-01-20 Sali di acidi retinoici per il trattamento della psoriasi IT201700006374A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102017000006374A IT201700006374A1 (it) 2017-01-20 2017-01-20 Sali di acidi retinoici per il trattamento della psoriasi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000006374A IT201700006374A1 (it) 2017-01-20 2017-01-20 Sali di acidi retinoici per il trattamento della psoriasi

Publications (1)

Publication Number Publication Date
IT201700006374A1 true IT201700006374A1 (it) 2018-07-20

Family

ID=58995048

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000006374A IT201700006374A1 (it) 2017-01-20 2017-01-20 Sali di acidi retinoici per il trattamento della psoriasi

Country Status (1)

Country Link
IT (1) IT201700006374A1 (it)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934028A (en) * 1974-04-22 1976-01-20 The Regents Of The University Of California Acne and psoriasis treatment with retinoic acid analogs
IT1161221B (it) * 1983-04-21 1987-03-18 Ripharm Srl Composto per il trattamento della psoriasi
WO1996034601A1 (en) * 1995-05-05 1996-11-07 Braiman Mark S Treatment of psoriasis with 11-cis-retinoic acid
US5719195A (en) * 1995-05-05 1998-02-17 4 Thought Technologies Treatment of psoriasis with 11-cis-retinoic acid
WO2012032493A1 (en) * 2010-09-10 2012-03-15 Laboratori Farmaceutici Krymi S.P.A. Peel -off polyvinyl facial mask for treatment of skin conditions comprising a high concentraton of retinoic acid
WO2016001419A1 (en) * 2014-07-04 2016-01-07 Biagioni Daniele Pharmaceutical compositions for the treatment of psoriasis

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934028A (en) * 1974-04-22 1976-01-20 The Regents Of The University Of California Acne and psoriasis treatment with retinoic acid analogs
IT1161221B (it) * 1983-04-21 1987-03-18 Ripharm Srl Composto per il trattamento della psoriasi
WO1996034601A1 (en) * 1995-05-05 1996-11-07 Braiman Mark S Treatment of psoriasis with 11-cis-retinoic acid
US5719195A (en) * 1995-05-05 1998-02-17 4 Thought Technologies Treatment of psoriasis with 11-cis-retinoic acid
WO2012032493A1 (en) * 2010-09-10 2012-03-15 Laboratori Farmaceutici Krymi S.P.A. Peel -off polyvinyl facial mask for treatment of skin conditions comprising a high concentraton of retinoic acid
WO2016001419A1 (en) * 2014-07-04 2016-01-07 Biagioni Daniele Pharmaceutical compositions for the treatment of psoriasis

Similar Documents

Publication Publication Date Title
HK1223369A1 (zh) 用於治療氧化應激障礙的羧酸衍生物
SMT201600047B (it) Inibitore della chinasi di regolazione dei segnali dell'apoptosi
FR3027505B1 (fr) Procede de controle du positionnement de dents
IT201700081018A1 (it) Trattamento di segnali elettrofisiologici
CR20160496A (es) Inhibidores espirocíclicos sustituidos de la autotaxina
MA42032A (fr) Acides 3-aryl-4-amido-bicyclo [4,5,0]hydroxamiques en tant qu'inhibiteurs de hdac
DK2717692T3 (da) Tetrahydrocannabinol-11-syrer til anvendelse til behandling af fibrotiske sygdomme
DK3169328T3 (da) Quinolinderivater til behandling af inflammationssygdomme
DK3485890T3 (da) Sglt2-hæmmere til behandling af stofskifteforstyrrelser hos hundedyr
EA201890185A1 (ru) Способы лечения опосредованных гепсидином нарушений
IL254653A0 (en) Methods of treating liver disease using indane acetic acid history
DK3164394T3 (da) Gls1-inhibitorer til behandling af sygdomme
IT201600097482A1 (it) Metodo per il trattamento superficiale di un manufatto
DK3578562T3 (da) L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme
EP3593803A4 (en) COMPOUNDS FOR TREATING DISEASES CAUSED BY OXALATE ACCUMULATION
FI20136184L (fi) Menetelmä maidon käsittelemiseksi
DK3049100T3 (da) Modificerede fibroblastvækstfaktorer-1 til behandling af øjenlidelser
FR3002771B1 (fr) Procede de production d'acrylate de 2-propyl heptyle par transesterefication
ITUB20152036A1 (it) Cabina di spruzzatura per il trattamento di pelli
IT201700074911A1 (it) Procedimento per la produzione di olefine da alcoli
IT201700031928A1 (it) Bottale perfezionato per il trattamento di bottalatura delle pelli
SMT201700072B (it) Utilizzo del pidotimod per il trattamento della psoriasi
MA51822A (fr) Extraction d'acides alcanoïques
IT201700006374A1 (it) Sali di acidi retinoici per il trattamento della psoriasi
ITUB20160121A1 (it) Gabapentina oftalmica per il trattamento di ulcere corneali